Medical video assisted thoracoscopy – minimally invasive diagnostic tool for diagnosis of undiagnosed pleural effusion  by Eldaboosy, Safwat Ali M. et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2013) 62, 121–126The Egyptian Society of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis
www.elsevier.com/locate/ejcdt
www.sciencedirect.comORIGINAL ARTICLEMedical video assisted thoracoscopy – minimally invasive
diagnostic tool for diagnosis of undiagnosed pleural eﬀusionSafwat Ali M. Eldaboosy a,*, Mousa El-shamly a, Khalid M. Halima a,
Ahmad T. Shaarawy a, Ismail Alwakil a, Mohammad Osama ba Chest Diseases, Faculty of Medicine, Al-Azhar University, Egypt
b Public Health and Community Medicine Department, Faculty of Medicine, Al-Azhar University, EgyptReceived 23 October 2012; accepted 18 February 2013
Available online 23 March 2013*
E-
Pe
D
04
OpKEYWORDS
Medical thoracoscopy;
Pleural effusionCorresponding author. Tel.:
mail address: drsafwatchest@
er review under responsibil
iseases and Tuberculosis.
Production an
22-7638 ª 2013 The Egyptia
en access under CC BY-NC-ND li+2 0100
yahoo.c
ity of Th
d hostin
n Society
httpcense.Abstract Background: The diagnosis of pleural diseases is one of the frequent clinical problems
encountered in pulmonary medicine. A variety of diagnostic tests are available for evaluating pleu-
ral effusions. It often depends much more on the revealing results of pleural ﬂuid cytology and his-
topathological examination of the visceral or parietal pleural. Despite thoracocentesis and pleural
biopsy, approximately 15–20% of pleural effusions remains undiagnosed.
Aim of Work: This studywas carriedout to establish the efﬁcacy and safety ofmedicalVideoAssisted
Thoracoscopic (VAT) procedure as a diagnostic modality in undiagnosed exudative pleural effusion.
Patients andmethods: Thoracoscopywasperformedon 71patients for diagnostic purposes over a per-
iod of 2 years from June 2010 toAugust 2012, in theDepartment ofChest diseases, El-HusseinUniversity
Hospital, Al-Azhar University. Diagnostic thoracoscopy for pleural abnormality was carried out only
after pleural ﬂuid examinations and additional closed pleural biopsy was also performed. Histopatholo-
gical specimen was taken in all cases.
Results: Thoracoscopy gives the ﬁnal diagnosis in 62 cases (87.3%) from totally 71 cases. The most
common diagnosis was malignant mesothelioma in 39 cases (54.9%), malignant adenocarcinoma and
TB pleurisy in 10 cases (14.1%) for each, non Hodgkin’s lymphoma in 2 cases (2.8%), and lastly malig-
nant melanoma in one case (1.4%).
Conclusion: Medical VAT is a safe and accurate diagnostic procedure for pleural diseases but it also
has a very useful role in therapy.VAT saves time, effort and cost,moreover it is preferred by the patient as
he recovers and returns to his normal activity rapidly.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.3368540.
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Even after extensive diagnostic evaluation of a patient with
pleural effusion, the etiology often remains unclear. Pleural
ﬂuid studies and blind pleural biopsy have their own limita-
tions. It is in this context that pleuroscopy or thoracoscopy be-
comes an important investigation so that the pleural surface
can be visualized and the representative sample can easily be
picked. The concept of medical thoracoscopy is a simpliﬁca-
tion of VAT, as it is done under conscious sedation through
a single port by the chest physicians [1].
Medical thoracoscopy was ﬁrst introduced in 1866 by Gor-
don who observed the thoracic cavity with a binocular instru-
ment in a case of purulent effusion. Gordon was followed by
Hans Jacobaeus, a Swedish internist in 1910 [2].
Medical thoracoscopy is a minimally invasive procedure
performed by the pneumologist in an endoscopy suite. It also
allows for basic diagnostic (undiagnosed pleural ﬂuid or pleu-
ral thickening) and therapeutic procedures (pleurodesis) to be
performed safely In Europe, thoracoscopy is intrinsic in the
training program of pneumology [3]. In the USA, according
to a national survey in 1994, only 5% of all pulmonologists
were applying medical thoracoscopy [4].
Experienced pulmonologists perform ‘‘medical thoraco-
scopical’’ interventions at the sympathetic chain, pericardium,
mediastinum using ‘‘medical thoracoscopical’’ equipment and
deep sedation or general anesthesia using single lumen intro-
duction [3–4]. The main indications of medical thoracoscopy
are the diagnosis and treatment of pleural effusions and pneu-
mothorax. In pleural effusions medical thoracoscopy provides
the proof or exclusion of malignancy and tuberculosis with an
accuracy approaching 100%. As a staging procedure it helps
determine the etiology and extent, and possibly, prognosis of
malignant effusions as well as treatment strategies. Medical
thoracoscopy has also proved to be successful in the manage-
ment of empyema and of spontaneous pneumothorax. In the
future, it may become even more popular once more respira-
tory physicians are trained in the procedure [3].
Aim of the work
The aim of this study is to establish the efﬁcacy and safety of
medical Video Assisted Thoracoscopic (VAT) procedure as a
diagnostic modality in undiagnosed pleural effusion.
Subjects and methods
Seventy one patients who were diagnosed to have pleural effu-
sion of unknown etiology, participated in this study. They
were selected from the Department of Chest diseases, El-Hus-
sein University Hospital, Al-Azhar University over a period of
2 years from June 2010 to August 2012.
All the patients were subjected to the following – complete
medical history and physical examination, plain chest X-ray
(postero-anterior and lateral views). CT scanning of the chest,
blood count, erythrocyte sedimentation rate (ESR), liver func-
tion tests, renal function tests, bleeding proﬁle (prothrombin
time and concentration), and arterial blood gases if needed.
Sputum smears examination for the presence of Acid Fast Ba-
cilli (AFB) on three successive days ‘‘in cases with sputum pro-
duction or Sputum analysis for malignancy, tuberculin test,and electrocardiogram. Thoracocentesis pleural ﬂuid was aspi-
rated and sent for: chemical quantiﬁcation of proteins, LDH
and glucose content, bacterial studies for the presence of
AFB. Cytological examinations for the presence of malignant
cells by H&E or Papnicolou stain, cells denoting speciﬁc infec-
tions. Abrams needle biopsy and histopathological examina-
tion. Exclusion criteria:
The following patients were excluded from the study: Patients
with transudative pleural effusion, according to Lights’ criteria.
Patients whose initial pleural ﬂuid examination was diagnostic
for a speciﬁc disease or those who were judged not in need for
more invasive procedures. Patients who could not with stand
the lateral decubitus for a period long enough to perform the tho-
racoscopy procedure (usually in the range of 30–60 min). Patients
with severe uncorrected hypoxemia despite the administration of
supplemental oxygen. Patients with unstable cardiovascular or
hemodynamic status. Patients with coagulation defects. As those
patients with prothrombin concentrations less than 60% and or
those with platelet count less than 60,000 c/mm. Patients in
whom the pleural space was judged by radiological examination
to be inaccessible easily, those who had their pleural space oblit-
erated by ﬁbrous tissue, or those who were suspected of having
multiloculated effusions. Patients with veryminimal pleural ﬂuid
that could not be easily accessed.Methods
Thoracoscopic procedure
Prethoracoscopic assessment
Before pleuroscopy radiologic evaluation should routinely in-
clude a posteroanterior and lateral chest radiograph. A CT scan
is not mandatory but may be helpful in certain situations such
as loculated effusion and localized lesions of the chest wall or
diaphragm. Evaluation of the patient’s respiratory status re-
quires at a minimum an ABG analysis. An ECG has to be taken
to exclude recent myocardial infarction or signiﬁcant arrhyth-
mia. Other laboratory parameters include coagulation parame-
ters, serum electrolytes, blood glucose, blood group, platelet
count, liver function tests, and serum creatinine. Informed con-
sent must be obtained from the patient. An informed consent
was taken and the procedure was explained to each patient.
Thoracoscopic procedure
The patient was placed on the operating table, and chest is pre-
pared and draped as for thoracotomy, in the endoscopic unit.
The patient was placed in a lateral decubitus position with the
involved side upward and connected with the monitoring sys-
tem ‘‘ECG, respiratory rate, and pulse oximetry’’. After skin
sterilization, the 4th/5th–6th intercostal spaces in the mid-
axillary line have evolved as an almost standard entry point
providing an optimum overview of the pleural cavity.
The next step is to obtain local anesthesia
Pleuroscopy by the single entry technique is done under local
anesthesia (50–100 mg lidocaine inﬁlteration) with premedica-
tion using an (midazolam 5–10 mg 2–5 min before procedure)
anxiolytic, a narcotic or both. If required additional pain med-
ication may be given during the procedure.
Table 1 General characteristics of the studied sample.
Variables Patients (No. = 71)
Age (yrs)
Mean ± SD 54.5 ± 12.8
Min–Max 2781
No. %
Sex
Males 39 54.9
Females 32 45.1
Residence
Urban 45 63.4
Rural 26 36.6
Occupation
House wife 32 45.1
Pensioner 13 18.3
Masons 26 36.6
Smoking habit
Smoker 39 54.9
Non-smoker 32 45.1
Table 2 Role of the thoracoscope in the diagnosis of
undiagnosed pleural effusion by the usual methods in the
studied sample.
Role of the thoracoscope in the diagnosis No. %
Diagnosed cases 62 87.3
Malignant mesothelioma 39 54.9
Metastatic adenocarcinoma 10 14.1
Non Hodgkin’s lymphoma 2 2.8
Metastatic malignant melanoma 1 1.4
TB pleurisy 10
Undiagnosed cases (non speciﬁc pleuritis) 9 12.7
Total 71 100.0
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injecting enough lidocaine, (up to 3 mg/kg of lidocaine),
approximately 0.5 mL, to raise a small wheal. The small needle
is then replaced by a 1.5-inch. long 22-gauge needle. This nee-
dle is inserted to the periosteum of the underlying rib and is
moved up and over the rib with frequent injection of small
amounts (0.1–0.2 mL) of lidocaine. Once this needle is superior
to the rib, it is slowly advanced toward the pleural space with
aspiration, followed by the injection of 0.1–0.2 mL of lidocaine
every 1–2 mm. Liberal amounts of lidocaine should be injected
once the rib is passed to ensure adequate anesthesia of the pari-
etal pleura. This frequent aspiration and the injection of lido-
caine guarantee anesthesia of the parietal pleura.
Single puncture technique was used in the present study,
chest was entered carefully through a stab incision, a 2 cm inci-
sion was made, digital palpation determined the presence of
adhesions and bleeders from the wound were checked. If none
was present an 11 mms trocar was inserted though which the
10 mm rigid telescope was inserted with avoiding uncontrolled
deep penetration. Then evacuation of the entire ﬂuid collection
and ipsilateral pneumothorax was induced.
Introduction of the telescope was done to explore entire
pleural cavity, angled telescope allows visualization of remote
or concealed lesions. The entire thoracic cavity was then care-
fully explored, by means of projecting images on the video
monitor, and this is recommended for documentation in the
patient ﬁles. Visualization of the contents of the pleural cavity
is facilitated by a video camera that is attached to the eyepiece
of the rigid telescope.
After that biopsies were generally taken from the suspicious
area, copious and multiple biopsies were taken for histopathol-
ogical examination with an optional blunt dissection instru-
ment for impeding adhesions and breaking of septae and
membranes followed by the insertion of an intercostal chest
tube in the optimal position and ﬁxation of the tube at the pen-
etration site. Chest–X-ray was done to conﬁrm the tube posi-
tion and correct drain function, and ﬁnally removal of the
drain and suturing of the insertion site was done as soon as sta-
ble lung expansion was achieved and the drainage became min-
imal (less than 50 cc/day) or no air leak was detected. The
patient was discharged from the hospital 1 or 2 days after
the removal of the intercostal tube without the need for inten-
sive care unit stay.Results
The mean age of the studied sample was (54.5 + 12.8) years
with ages ranging from 27 to 81 years. Less than half of them
were females (45.1%) who were house wives and non-smokers.
About (63%) were living in urban areas (see Tables 1–6).
Thoracoscopy gives the ﬁnal diagnosis in 62 cases (87.3%)
from totally 71 cases. The most common diagnosis was malig-
nant mesothelioma in 39 cases (54.9%), malignant adenocarci-
noma and TB pleurisy in 10 cases (14.1%) for each, non
Hodgkin lymphoma in 2 cases (2.8%), and lastly malignant
melanoma in one case (1.4%).
Complications were found in 8 cases (11.3%), 5 cases
showed surgical emphysema, 2 cases developed postprocedure
empyema, 1 case showed bronchopleural ﬁstula).
Among the diagnosed cases, 30 cases (42.3%) with malig-
nant mesothelioma were living in urban areas compared to 9cases (12.6%) in rural areas with statistically signiﬁcant
difference.
Among the diagnosed cases, 24 cases (33.8%) with malig-
nant mesothelioma were males compared to 15 cases (21.1%)
who were females. Malignant adenocarcinoma was more pre-
valent among females while TB pleurisy was more prevalent
among males with no statistical signiﬁcant difference.
Among the diagnosed cases, 23 cases (32.4%) with malig-
nant mesothelioma were smokers compared to 16 cases
(22.5%) who were non-smokers. Malignant adenocarcinoma
was more prevalent among non-smokers while TB pleurisy
was more prevalent among smokers with no statistically signif-
icant difference.
Discussion
Thoracoscopy as a useful diagnostic and therapeutic modality,
in spite of thoracentesis and pleural biopsy, approximately 15–
20% of pleural effusions remain undiagnosed. Cytological
examination is diagnostic in only 60–80% of patients with met-
astatic pleural involvement and in 20% of the patients with
mesothelioma; however, thoracoscopic parietal pleural exami-
nation and biopsy present a valuable opportunity to achieve
the earlier diagnosis [5].
Table 3 Distribution of the studied sample according to the presence of complications.
Complications N %
Present (5 cases surgical emphysema, 2 cases postprocedure empyema, 1 case of bronchopleural ﬁstula) 8 11.3
Absent 63 88.7
Total 71 100.0
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54.4 + 12.6 years. Thirty nine patients (54.4%) of the studied
group were males while 32 patients (45.6%) were females.
Most of the patients were housewives 32 cases (45.1%), 26
cases (36.6%) were masons, and 13 cases (18, 3%) were pen-
sioners. There were 39 patients (54.4%) who were smokers
and 32 patients (46.6%) non smokers.
Our study found that thoracoscopy gives the ﬁnal diagnosis
in 62 cases (87.3%) from a total of 71 cases. This is in agree-
ment with Zhang et al. who studied the role of thoracoscope
in diagnosing and managing pleural effusions. They examined
146 patients with pleural effusions and they attained histolog-
ical diagnosis in 127 patients (86.9%) [6]. In Boutin’s series, in
1991, the sensitivity of biopsy increased with the years rising
from 72% early in the experience to 97% later on. False neg-
ative ﬁndings were due to adhesions that hinder access to the
neoplastic tissue [7]. Other investigators have also found simi-
lar levels of diagnostic accuracy in excess of 88% [8]. Several
studies have tried to determine the diagnostic accuracy of pleu-
roscopy in the setting of undiagnosed effusions but the results
vary widely with a range of 60–90% [9].
Medical thoracoscopy should be performed on these undi-
agnosed patients because of its high sensitivity in malignant
and tuberculous pleural effusions [10]. By means of thoracos-
copy the proportion of so called idiopathic pleural effusions
usually falls markedly below 10% [7].
Different studies had shown that thoracoscopic sensitivity
is less than that of the present study such as Hucker and asso-
ciates who had a positive diagnosis in (80.3%) of 102 patients
with recurrent pleural effusion which was not been achieved by
conventional methods [11]. Also Kendall and associates per-
formed video assisted thoracoscopy on 48 patients who had
undiagnosed pleural effusion and found the diagnostic sensi-
tivity to be 83% [12]. However, our results were relatively low-
er than Boutin et al. who showed a diagnostic accuracy of
(96%) in 215 patients undergoing thoracoscopy for pleural
effusion [13]. Also Menzies and Charbonneau reported a posi-
tive diagnosis in 96% of 86 patients who had undiagnosed
pleural effusion [8], Liu et al. reported (100%) diagnostic accu-
racy after VAT pleural biopsy [14]. Francois et al. reported
that the diagnostic efﬁciency of medical thoracoscopy was
(93.3%) [15]. Medical thoracoscopy also yielded a deﬁnite
diagnosis with an overall efﬁciency of 93.3% in a study done
by Akle et al. [16] and this ﬁnding correlates with those found
by Al-Halafawy et al. [17]. The above mentioned results were
higher than the results we got because most of them did not
exclude cases diagnosed by thoracentesis or blind pleural
biopsy. But in the present study all patients which were diag-
nosed by the above two methods were excluded from the
study.
In our study 9 cases of total 71 patients were diagnosed as
nonspeciﬁc pleuritis after thoracoscopy. A ‘‘wait and see’’ ap-
proach is therefore justiﬁed in the majority of these patientsand the patients should be monitored with regular chest radi-
ography. This speciﬁc problem has been retrospectively ad-
dressed and after thoracoscopy less than 10% of the cases of
initially suspected pleural effusion are diagnosed as having
nonspeciﬁc (idiopathic) pleuritis. During the follow-up period
of those with nonspeciﬁc pleuritis, only 4–8% of patients
present a malignancy after repeated thoracoscopies. Most of
the cases (up to 80%) follow a true benign course with sponta-
neous resolution, while few cases are ‘idiopathic’ [18,19].
Dhanya and Ravindran carried out diagnostic thoracoscopy
for pleural abnormality and histopathological specimen was
taken in all 45 patients, out of which 15 were proved to be
malignant, caseating granuloma was reported in 3 cases,
Hydatid disease in one and non speciﬁc inﬂammatory changes
in 10 cases [20].
In the present study we found that the most common diag-
nosis was malignancy in 52 cases (83.8%) then TB pleurisy in
10 patients (16.2%). The most common diagnosis in this study
was malignant mesothelioma in 39 cases (54.9%), malignant
adenocarcinoma and TB pleurisy in 10 cases (14.1%) for each,
non Hodgkin’s lymphoma in 2 cases (2.8%), and lastly malig-
nant melanoma in one case (1.4%).
In developed countries, thoracoscopy is very important as
there is a signiﬁcant likelihood of malignancy in patients with
undiagnosed pleural effusions. Indeed, in developed countries
where the incidence of tuberculosis is low, more than 50% of
the cases of undiagnosed pleural effusion are due to carcino-
mas, the second most common (10%) being tuberculosis [21].
In developing countries (as Egypt) the incidence of TB (and
TB pleurisy) is still high.
The results reported by Dhanya and Ravindran were less
than our results regarding malignant pleural mesothelioma
as detected in 8 patients (47.1%) however; metastatic adeno-
carcinoma was lower than our results as detected in 6 patients
(35.3%) [20]. In the study by Lee et al., all (52) patients had
malignant involvement of the pleura, of which 9 were mesothe-
liomas. They also share the same observations in 45 patients
with pleural effusions of unclear etiology. Thirty two patients
have pleural metastases (71%), 12 have pulmonary tuberculo-
sis (24%) and 1 with chronic pleuritis [21].
These ﬁgures reﬂect the high incidence of this lethal malig-
nant mesothelioma among pleural malignancies in our country
and attract the attention toward the necessity of more strict
application of laws prohibiting the use of asbestos in industry.
The rate of incidence of mesothelioma has fallen to its lowest
levels in the United States after it has peaked in the 1980s; it is
still high in the United Kingdom but will disappear rapidly
after 2020 [22]. In contrary to our results, Cugell and Kamp
reported a higher percentage of metastatic malignancy to the
pleura as encountered in 8 patients out of 20 (40%). Metastatic
adenocarcinoma was the most common pathological ﬁnding (4
patients out of 8) (50%). The most important advantage of
thoracoscopy in these patients was that there was no doubt
Table 5 Distribution of diagnosed cases by thoracoscope among the studied sample in relation to sex.
Sex Diagnosed cases by thoracoscope
Malignant
mesothelioma
Malignant
adenocarcinoma
Non Hodgkin’s
lymphoma
Malignant
melanoma
TB pluerisy
NO. % NO. % NO. % NO. % NO. %
Male 24 33.8 3 4.2 1 1.4 1 1.4 6 8.5
Female 15 21.1 7 9.9 1 1.4 0 0.0 4 5.6
Total 39 54.9 10 14.1 2 2.8 1 1.4 10 14.1
Chi-
square
4.5 P-value 0.47
Table 4 Distribution of diagnosed cases by thoracoscope among the studied sample in relation to residence.
Residence Diagnosed cases by thoracoscope
Malignant
mesothelioma
Malignant
adenocarcinoma
Non Hodgkin’s
lymphoma
Malignant
melanoma
TB pleurisy
No. % No. % No. % No. % No. %
Urban 30 42.3 6 8.5 0 0.0 1 1.4 6 8.5
Rural 9 12.6 4 5.6 2 2.8 0 0.0 4 5.6
Total 39 54.9 10 14.1 2 2.8 1 1.4 10 14.1
Chi-
square
11.8 P-value 0.04
Table 6 Distribution of diagnosed cases by thoracoscope among the studied sample in relation to cigarette smoking habit.
Smoking
habit
Diagnosed cases by thoracoscope
Malignant
mesothelioma
Malignant
adenocarcinoma
Non Hodgkin’s
lymphoma
Malignant
melanoma
TB pleurisy
NO. % NO. % NO. % NO. % NO. %
Smokers 23 32.4 3 4.2 1 1.4 1 1.4 6 8.5
Non
smokers
16 22.5 7 9.9 1 1.4 0 0.0 4 5.6
Total 39 54.9 10 14.1 2 2.8 1 1.4 10 14.1
Chi-square 4.0 P-value 0.54
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metastatic adenocarcinoma due to relatively larger size of spec-
imens collected [23].
In this study non Hodgkin’s lymphoma in 2 cases (2.8%),
and lastly malignant melanoma in one case (1.4%) were pres-
ent. .This result was matched with Steven who reported that,
the diagnosis of pleural effusions was rare in Hodgkin’s disease
but not infrequent in non-Hodgkin’s lymphoma. Pleural effu-
sions could be found in previously untreated patients with
non-Hodgkin’s lymphoma, even in the absence of detectable
intrathoracic lymphadenopathy. At autopsy in Hodgkin’s dis-
ease, lymphomatous invasion appears to be an uncommon
and late ﬁnding but is seen with increased frequency in non-
Hodgkin’s disease. The mechanism of effusion in Hodgkin’s
lymphoma might be due to either impaired lymphatic drainage
(most common) secondary to mediastinal lymphadenopathy,
pleural or pulmonary inﬁltrates or thoracic duct obstruction
while in non-Hodgkin’s lymphoma direct pleural inﬁltration
was the predominant mechanism of effusion [24]. Butmetastatic malignant melanoma as the cause of malignant
pleural effusion was not reported in any study.
In this study no mortality related to the procedure was pres-
ent and thoracoscopic complications were found in 8 cases
(11.3%); 5 cases showed subcutaneous emphysema, 2 cases
developed post procedure empyema, 1 case showed broncho-
pleural ﬁstula sealed within 3 days). However, Harries et al.
also reported 11 patients (5%) of 182 patients who died after
VAT with no procedure-related post operative deaths [25].
Thoracoscopy is one of the safest pulmonologic examinations.
Boutin et al., 1981 reviewed 4300 thoracoscopy cases and they
found that mortality was 0.09% and empeyma occurred in 12
out of 652, hemorrhage occurred in 6 patients of 256, and clin-
ically signiﬁcant subcutaneous emphysema was reported in
only a few cases [13].
Robert et al. in their study on 367 patients with pleural
effusion who underwent VAT reported complications in 7 pa-
tients (2%) and there were three operative deaths not related to
operative procedure [26].
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Thoracoscopy is an old, safe and simple procedure. Any pul-
monologist who deals with pleural disease nowadays should
be able to perform thoracoscopy. The diagnostic yield of pleu-
ral effusions under thoracoscopy is high (85–.90%). Thoracos-
copy, performed under local anesthesia in the endoscopy suite,
gives solutions in more than 95% of undiagnosed pleural effu-
sions, with minimal and mild complications. It is a method
widely applied by many respiratory physicians to whom a pa-
tient with pleural effusion must be referred immediately after a
negative initial work-up.
Recommendations
Every pulmonologist should be aware and well trained about
thoracoscopy.
Thoracoscopy may replace the need for second closed pleu-
ral biopsy in un-diagnosed pleural effusion.
Any pulmonologist who deals with pleural disease nowa-
days should be able to perform thoracoscopy.
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